Alicia J Hager Net Worth & Insider Trades

Alicia J Hager - SVP and General Counsel, Oncomed Pharmaceuticals Inc

As of April 23, 2019

What is Alicia J Hager's Net Worth?

The current estimated net worth of Oncomed Pharmaceuticals Inc's SVP and General Counsel, Alicia J Hager, is estimated to be about $676.16K . Alicia J Hager owns about 51,754 units of Oncomed Pharmaceuticals Inc common stock. In the last 5 years at Oncomed Pharmaceuticals Inc, Alicia J Hager has sold an estimated value of $449.03K worth.

What is Alicia J Hager's Past Insider Trading?

Alicia J Hager's largest purchase order was 6,652 units , worth over $22.75K on March 17, 2017. Alicia J Hager's largest sale order was 5,400 units , worth over $113.4K on October 29, 2015. In total, Alicia J Hager has made about 21 transactions over 5 years of their time at Oncomed Pharmaceuticals Inc. Alicia J Hager usually trades in October, with the busiest year in 2015. The most recent transaction was a sale order of 1,156 units , worth over $2.34K on October 11, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Alicia J Hager's Salary in 2017?

As SVP and General Counsel of Oncomed Pharmaceuticals Inc, Alicia J Hager has a total base salary of $347,619 . Alicia J Hager received compensation valued at about $1,432,262 in 2017 after becoming SVP and General Counsel. The vast majority of their compensation came in the form of stock awards of $154,536 , option awards of $804,964 , and other earnings, plans or compensations of $125,143 .

What is Alicia J Hager's' Mailing Address?

  • Mailing address is C/o Oncomed Pharmaceuticals, Inc. 800 Chesapeake Drive Redwood City CA 94063 CA

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

What are Oncomed Pharmaceuticals Inc's Past Insider Trades?

Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel .

OncoMed Pharmaceuticals Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1